James A. Inciardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James A. Inciardi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hilary L. Surratt
University of Kentucky
3 shared publications Steven P. Kurtz
Center for Drug and Alcohol Studies , University of Delaware , Coral Gables, FL
3 shared publicationsTheodore J. Cicero
Washington University , St. Louis, MO
3 shared publicationsAlvaro Muñoz
Johns Hopkins University, Bloomberg School of Public Health , 615 North Wolfe Street, Room E7008, Baltimore, MD, 21205-2179, USA
1 shared publicationAnne Geller
1 shared publicationEdgar H. Adams
1 shared publication
Latest Publications
- 7 October 2009
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 28 (4) , 332-347
The “Black Box” of Prescription Drug Diversion
A variety of surveys and studies are examined in an effort to better understand the scope of prescription drug diversion and to determine whether there are consistent patterns of diversion among various populations of prescription drug abusers. Data are drawn from the RADARS System, the National Survey of Drug Use and Health, the Delaware School Survey, and a series of quantitative and qualitative studies conducted in Miami, Florida. The data suggest that the major sources of diversion include drug dealers, friends and relatives, smugglers, pain patients, and the elderly, but these vary by the population being targeted. In all of the studies examined, the use of the Internet as a source for prescription drugs is insignificant. Little is known about where drug dealers are obtaining their supplies, and as such, prescription drug diversion is a “black box” requiring concentrated, systematic study.
- 7 October 2009
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 28 (4) , 332-347
The “Black Box” of Prescription Drug Diversion
A variety of surveys and studies are examined in an effort to better understand the scope of prescription drug diversion and to determine whether there are consistent patterns of diversion among various populations of prescription drug abusers. Data are drawn from the RADARS System, the National Survey of Drug Use and Health, the Delaware School Survey, and a series of quantitative and qualitative studies conducted in Miami, Florida. The data suggest that the major sources of diversion include drug dealers, friends and relatives, smugglers, pain patients, and the elderly, but these vary by the population being targeted. In all of the studies examined, the use of the Internet as a source for prescription drugs is insignificant. Little is known about where drug dealers are obtaining their supplies, and as such, prescription drug diversion is a “black box” requiring concentrated, systematic study.
- Open Access
- 14 February 2007
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 8 (2) , 171-183
Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations
Objective. Prescription drug diversion involves the unlawful channeling of regulated pharmaceuticals from legal sources to the illicit marketplace, a
- 14 February 2007
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 8 (2) , 171-183
Open AccessMechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations
Objective. Prescription drug diversion involves the unlawful channeling of regulated pharmaceuticals from legal sources to the illicit marketplace, a
- 18 August 2006
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 25 (2) , 53-58
The Diversion of Ultram®, Ultracet®, and Generic Tramadol HCl
Ultram® (tramadol HCl) was approved by the Food and Drug Administration in 1994 as a non-scheduled drug under the Controlled Substance Act. The non-scheduled status was contingent on the development and implementation of a comprehensive postmarketing surveillance program by an Independent Steering Committee external to Ortho-McNeil Pharmaceutical charged with monitoring abuse and recommending scheduling if unexpectedly high abuse occurred. The program developed by this committee was composed of a variety of studies, and the results of the first three years of the surveillance efforts revealed that the rate of Ultram abuse was low. At a meeting of the FDA in 1998 to reexamine the scheduling status of Ultram, it was recommended that the scope of the postmarketing surveillance program be broadened to include data on diversion. After one year pilot study, by January 2002, a nationwide diversion survey was fully operational. This brief communication describes the experiences of this diversion study, a...
- 18 August 2006
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 25 (2) , 53-58
The Diversion of Ultram®, Ultracet®, and Generic Tramadol HCl
Ultram® (tramadol HCl) was approved by the Food and Drug Administration in 1994 as a non-scheduled drug under the Controlled Substance Act. The non-scheduled status was contingent on the development and implementation of a comprehensive postmarketing surveillance program by an Independent Steering Committee external to Ortho-McNeil Pharmaceutical charged with monitoring abuse and recommending scheduling if unexpectedly high abuse occurred. The program developed by this committee was composed of a variety of studies, and the results of the first three years of the surveillance efforts revealed that the rate of Ultram abuse was low. At a meeting of the FDA in 1998 to reexamine the scheduling status of Ultram, it was recommended that the scope of the postmarketing surveillance program be broadened to include data on diversion. After one year pilot study, by January 2002, a nationwide diversion survey was fully operational. This brief communication describes the experiences of this diversion study, a...
- 1 January 2006
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 41 (2) , 255-264
The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio
Data are reported from drug diversion cases involving health care workers who were investigated by the Cincinnati Police Division Pharmaceutical Diversion Squad over an 11-year period. This type of information is rarely available because few U.S. police jurisdictions dedicate resources to prescription drug diversion surveillance. Data from 1992 through 2002 show that opioids were the drugs most commonly diverted by health care workers, followed by benzodiazepines. Nurses, nursing assistants, and medical assistants were involved in almost three quarters of all cases. Hospitals were the most common sources of complaint to police, followed by pharmacies. Health care professional associations are advised to promote greater awareness of drug misuse and dependence concerns among their memberships, and health care facilities that stock pharmaceuticals liable for misuse and diversion are advised to increase the security of their supplies.
- 1 January 2006
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 41 (2) , 255-264
The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio
Data are reported from drug diversion cases involving health care workers who were investigated by the Cincinnati Police Division Pharmaceutical Diversion Squad over an 11-year period. This type of information is rarely available because few U.S. police jurisdictions dedicate resources to prescription drug diversion surveillance. Data from 1992 through 2002 show that opioids were the drugs most commonly diverted by health care workers, followed by benzodiazepines. Nurses, nursing assistants, and medical assistants were involved in almost three quarters of all cases. Hospitals were the most common sources of complaint to police, followed by pharmacies. Health care professional associations are advised to promote greater awareness of drug misuse and dependence concerns among their memberships, and health care facilities that stock pharmaceuticals liable for misuse and diversion are advised to increase the security of their supplies.
- 6 April 1993
- Published by Taylor & Francis in Women & Health
- Vol. 20 (1) , 69-86
Women and AIDS
Female sexual partners of injection drug users are at risk for AIDS because of their association with street drug cultures and all their concomitant risks, including their own non-injecting drug use. This study examines a model of the social determinants of HTV-associated sexual risk behaviors. Multiple Linear regression analysis was used to analyze the data for 207 female sexual partners who had never injected drugs. The findings show that crack cocaine use is the strongest conhbutor to the model, which explains fourteen percent of the variance of sexual risk behavior. The fmdings suggest that the risks associated with sexual practices are much greater for crack cocaine users than among non users of crack.
- 6 April 1993
- Published by Taylor & Francis in Women & Health
- Vol. 20 (1) , 69-86
Women and AIDS
Female sexual partners of injection drug users are at risk for AIDS because of their association with street drug cultures and all their concomitant risks, including their own non-injecting drug use. This study examines a model of the social determinants of HTV-associated sexual risk behaviors. Multiple Linear regression analysis was used to analyze the data for 207 female sexual partners who had never injected drugs. The findings show that crack cocaine use is the strongest conhbutor to the model, which explains fourteen percent of the variance of sexual risk behavior. The fmdings suggest that the risks associated with sexual practices are much greater for crack cocaine users than among non users of crack.